Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Korkegian

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Drug Development Research|March 21, 2019
8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosisJoshua O Odingo, Julie V Early, Jake Smith, et al.
ACS Infectious Diseases|September 20, 2016
A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal PeptidaseShilah A Bonnett, Juliane Ollinger, Susantha Chandrasekera, et al.
Bioorganic & Medicinal Chemistry|June 4, 2017
The synthesis and evaluation of triazolopyrimidines as anti-tubercular agentsEdison S Zuniga, Aaron Korkegian, Steven Mullen, et al.
BMC Research Notes|June 30, 2018
Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosisSheo B Singh, Joshua Odingo, Mai A Bailey, et al.
Frontiers in Chemistry|May 17, 2021
Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against <i>Mycobacterium tuberculosis</i>Erik Hembre, Julie V Early, Joshua Odingo, et al.
Molecular Diversity|January 1, 2021
Design, synthesis and SAR of antitubercular benzylpiperazine ureasSohal Satish, Rohan Chitral, Amitkumar Kori, et al.
Scientific Reports|September 1, 2022
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screeningAnuradha Kumar, Somsundaram Chettiar, Brian S Brown, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosisMaria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.
Journal of Medicinal Chemistry|June 27, 2018
Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrBLaura A T Cleghorn, Peter C Ray, Joshua Odingo, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Drug Development Research|March 21, 2019
8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosisJoshua O Odingo, Julie V Early, Jake Smith, et al.
ACS Infectious Diseases|September 20, 2016
A Target-Based Whole Cell Screen Approach To Identify Potential Inhibitors of Mycobacterium tuberculosis Signal PeptidaseShilah A Bonnett, Juliane Ollinger, Susantha Chandrasekera, et al.
Bioorganic & Medicinal Chemistry|June 4, 2017
The synthesis and evaluation of triazolopyrimidines as anti-tubercular agentsEdison S Zuniga, Aaron Korkegian, Steven Mullen, et al.
BMC Research Notes|June 30, 2018
Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosisSheo B Singh, Joshua Odingo, Mai A Bailey, et al.
Frontiers in Chemistry|May 17, 2021
Novel Trifluoromethyl Pyrimidinone Compounds With Activity Against <i>Mycobacterium tuberculosis</i>Erik Hembre, Julie V Early, Joshua Odingo, et al.
Molecular Diversity|January 1, 2021
Design, synthesis and SAR of antitubercular benzylpiperazine ureasSohal Satish, Rohan Chitral, Amitkumar Kori, et al.
Scientific Reports|September 1, 2022
Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screeningAnuradha Kumar, Somsundaram Chettiar, Brian S Brown, et al.
Antimicrobial Agents and Chemotherapy|February 13, 2019
Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse ModelGregory T Robertson, Victoria A Ektnitphong, Michael S Scherman, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2018
Synthesis and biological evaluation of aryl-oxadiazoles as inhibitors of Mycobacterium tuberculosisMaria Angeles Martinez-Grau, Isabel C Gonzalez Valcarcel, Julie V Early, et al.
Journal of Medicinal Chemistry|June 27, 2018
Identification of Morpholino Thiophenes as Novel Mycobacterium tuberculosis Inhibitors, Targeting QcrBLaura A T Cleghorn, Peter C Ray, Joshua Odingo, et al.
Pageof 3